Acquired Pure Red Cell Aplasia Following Recombinant Erythropoietin (Darbepoetin-alfa) Therapy

Acquired pure red cell aplasia (PRCA) following use of recombinant erythropoietin (rEPO) is distinctly rare and sporadically reported in the literature. We discuss a case of PRCA following the usage of rEPO (darbepoetin-α) during the management of anemia of chronic kidney disease in an elderly male...

Descripción completa

Detalles Bibliográficos
Autores principales: Padhi, Somanath, Behera, Gayatri, Pattnaik, Sandeep Abhijit, Das, Prabodh Kumar, Adhya, Amit Kumar, Patra, Susama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132853/
https://www.ncbi.nlm.nih.gov/pubmed/32269436
http://dx.doi.org/10.4103/ijn.IJN_129_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132853/
https://www.ncbi.nlm.nih.gov/pubmed/32269436
http://dx.doi.org/10.4103/ijn.IJN_129_19

Ejemplares similares